Mark E. Reynolds

548 total citations
14 papers, 398 citations indexed

About

Mark E. Reynolds is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Mark E. Reynolds has authored 14 papers receiving a total of 398 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 3 papers in Radiology, Nuclear Medicine and Imaging and 2 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Mark E. Reynolds's work include Monoclonal and Polyclonal Antibodies Research (3 papers), Chemical Synthesis and Analysis (2 papers) and Computational Drug Discovery Methods (2 papers). Mark E. Reynolds is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (3 papers), Chemical Synthesis and Analysis (2 papers) and Computational Drug Discovery Methods (2 papers). Mark E. Reynolds collaborates with scholars based in United States, France and Belarus. Mark E. Reynolds's co-authors include Melissa A. Starovasnik, Gerald Nakamura, Henry B. Lowman, Todd C. Somers, Brent Blackburn, Kirk Robarge, Thomas E. Rawson, Robert S. McDowell, Thomas R. Gadek and Lawrence R. McGee and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Biochemistry.

In The Last Decade

Mark E. Reynolds

14 papers receiving 357 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark E. Reynolds United States	10	187	101	93	62	50	14	398
Miyuki Shimizu Japan	10	239 1.3×	37 0.4×	97 1.0×	36 0.6×	22 0.4×	19	362
Sébastien Schmitt France	14	318 1.7×	76 0.8×	96 1.0×	15 0.2×	17 0.3×	44	674
Alexandra Hicks United States	9	116 0.6×	36 0.4×	17 0.2×	74 1.2×	46 0.9×	27	348
Rina Kashi United States	15	175 0.9×	277 2.7×	17 0.2×	22 0.4×	92 1.8×	19	597
Jun Naito Japan	9	125 0.7×	26 0.3×	30 0.3×	85 1.4×	44 0.9×	40	364
Alexander T. El Gammal Germany	12	248 1.3×	20 0.2×	21 0.2×	35 0.6×	84 1.7×	21	482
Yoshiko Koga Japan	12	184 1.0×	186 1.8×	17 0.2×	28 0.5×	17 0.3×	16	361
Yoshiteru Sato Japan	12	253 1.4×	59 0.6×	68 0.7×	19 0.3×	36 0.7×	36	493
H Iwasaki Japan	6	194 1.0×	16 0.2×	11 0.1×	14 0.2×	108 2.2×	10	429
Julie Lee United States	9	160 0.9×	21 0.2×	32 0.3×	128 2.1×	117 2.3×	12	410

Countries citing papers authored by Mark E. Reynolds

Since Specialization

Citations

This map shows the geographic impact of Mark E. Reynolds's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark E. Reynolds with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark E. Reynolds more than expected).

Fields of papers citing papers by Mark E. Reynolds

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark E. Reynolds. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark E. Reynolds. The network helps show where Mark E. Reynolds may publish in the future.

Co-authorship network of co-authors of Mark E. Reynolds

This figure shows the co-authorship network connecting the top 25 collaborators of Mark E. Reynolds. A scholar is included among the top collaborators of Mark E. Reynolds based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark E. Reynolds. Mark E. Reynolds is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Grier, Tyson, et al.. (2020). Sleep duration and musculoskeletal injury incidence in physically active men and women: A study of U.S. Army Special Operation Forces soldiers. Sleep Health. 6(3). 344–349. 37 indexed citations

Hosokawa, Yuri, Douglas J. Casa, J. Trtanj, et al.. (2019). Activity modification in heat: critical assessment of guidelines across athletic, occupational, and military settings in the USA. International Journal of Biometeorology. 63(3). 405–427. 47 indexed citations

Reynolds, Mark E., et al.. (2019). Incidence and prevalence of selected refractive errors, active component, U.S. Armed Forces, 2001-2018.. PubMed. 26(9). 26–30. 6 indexed citations

McCarville, M. Beth, et al.. (2018). Dramatic bone remodeling following larotrectinib administration for bone metastasis in a patient with TRK fusion congenital mesoblastic nephroma. Pediatric Blood & Cancer. 65(10). e27271–e27271. 22 indexed citations

Turpin, Brian, Catherine M. Albert, Leo Mascarenhas, et al.. (2018). Abstract PR07: A pediatric phase 1 study of larotrectinib, a highly selective inhibitor of the tropomyosin receptor kinase (TRK) family: An updated analysis. Cancer Research. 78(19_Supplement). PR07–PR07. 1 indexed citations

Reynolds, Mark E., et al.. (2011). Interdependence of Drug Substance Physical Properties and Corresponding Quality Control Strategy. Journal of Pharmaceutical Sciences. 101(1). 312–321. 12 indexed citations

Stamos, Jennifer L., Charles Eigenbrot, Gerald Nakamura, et al.. (2004). Convergent Recognition of the IgE Binding Site on the High-Affinity IgE Receptor. Structure. 12(7). 1289–1301. 24 indexed citations

Nakamura, Gerald, et al.. (2002). Stable “zeta” peptides that act as potent antagonists of the high-affinity IgE receptor. Proceedings of the National Academy of Sciences. 99(3). 1303–1308. 47 indexed citations

Nakamura, Gerald, Melissa A. Starovasnik, Mark E. Reynolds, & Henry B. Lowman. (2001). A Novel Family of Hairpin Peptides That Inhibit IgE Activity by Binding to the High-Affinity IgE Receptor. Biochemistry. 40(33). 9828–9835. 45 indexed citations

10.

Rawson, Thomas E., et al.. (1995). Stereochemistry of the benzodiazepine based Ras farnesyltransferase inhibitors. Bioorganic & Medicinal Chemistry Letters. 5(13). 1335–1338. 5 indexed citations

11.

Marsters, James C., Robert S. McDowell, Mark E. Reynolds, et al.. (1994). Benzodiazepine peptidomimetic inhibitors of farnesyltransferase. Bioorganic & Medicinal Chemistry. 2(9). 949–957. 40 indexed citations

12.

McDowell, Robert S., Brent Blackburn, Thomas R. Gadek, et al.. (1994). From Peptide to Non-Peptide. 2. The de Novo Design of Potent, Non-peptidal Inhibitors of Platelet Aggregation Based on a Benzodiazepinedione Scaffold. Journal of the American Chemical Society. 116(12). 5077–5083. 82 indexed citations

13.

Webb, Robert R., Peter L. Barker, Mark E. Reynolds, et al.. (1994). Mono-N-alkylation of anthranilamides via quinazolinones. An efficient synthesis of G5598, a benzodiazepine dione gpIIbIIIa antagonist. Tetrahedron Letters. 35(14). 2113–2116. 29 indexed citations

14.

Marsters, James C., Mark E. Reynolds, Todd C. Somers, et al.. (1994). Peptidomimetic inhibitors of Ras farnesylation. Chemistry & Biology. 1. viii–ix. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact